Is innovation causing accessibility, timing issues for private drug plans?

17 January 2020 - Pharmaceutical companies and private payers can interact in different ways to ensure the right drugs are ...

Read more →

Why Canada won't end up as the drugstore to the U.S.

16 January 2020 - Although in theory the new U.S. import proposals could significantly affect Canadians and their drug supplies, their ...

Read more →

B.C. funding decision on pricey drug leaves teen with rare disease facing 'scary' future

13 January 2020 - Miles Ambridge just misses cut-off age to access Spinraza, a potentially life-changing treatment. ...

Read more →

Health insurance industry pooling mechanism makes high cost drugs accessible for record number of Canadians

14 January 2020 - The catastrophic expense of high cost drugs have been made affordable for a record number of ...

Read more →

Alignment of terminology

9 January 2020 - CADTH is aligning the terminology in the single drug review processes as follows: ...

Read more →

New CADTH process for cell and gene therapies

9 January 2020 - CADTH has undertaken an internal review of our processes for drugs and devices, and established a revised ...

Read more →

Canadian parents of babies with rare deadly disease look to Novartis treatment lottery

5 January 2020 - Canadian babies with a rare and often fatal muscle-wasting disease may soon have access to a ...

Read more →

Toronto parents of baby needing $2.8 million drug turn to Swiss drug maker's dose lottery as a last resort

31 December 2019 - Critics call on Ottawa to improve access to expensive drugs that treat rare diseases. ...

Read more →

'We can't wait': life-saving cystic fibrosis drugs hard to access, advocates say

22 December 2019 - 'There's just not a fair assessment of these drugs and therefore, Canadians can't get them'. ...

Read more →

Pickering mother with cystic fibrosis pleads for ‘miracle drug’ to come to Canada

16 December 2019 - A Pickering mother fighting cystic fibrosis is calling for all levels of government and stakeholders to ...

Read more →

Alberta changes coverage of biologic drugs for people with Crohn's, diabetes, arthritis

12 December 2019 - The provincial government says will free up hundreds of millions of dollars in health funding during the ...

Read more →

Canadian study shows substantial savings possible with use of biosimilar filgrastim

12 December 2019 - During this week’s annual meeting of American Society of Hematology, researchers from Canada reported that using biosimilar ...

Read more →

Alberta will force patients to switch from biologics to cheaper biosimilar medications

12 December 2019 - Alberta will force 26,000 patients on government-sponsored drug plans to switch from expensive drugs that are known ...

Read more →

Trudeau vague on scope of national pharmacare plan

9 December 2019 - New Democratic Party leader Jagmeet Singh says he can’t support the Liberal government’s Speech from the ...

Read more →

Innovative Medicines Canada bans members from paying doctors fees for IV infusions

11 December 2019 - Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous ...

Read more →